Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 30, 2020 08:00 ET | Source: SQZ Biotech

SQZ Biotech Announces First Patient Dosed in Phase 1 Trial of SQZ-PBMC-HPV for HPV+ Tumors

Trial is evaluating SQZ-PBMC-HPV as both monotherapy and in combination with a checkpoint inhibitor Multiple doses successfully manufactured for first patient in under 24 hours WATERTOWN, Mass.,...
November 12, 2019 08:00 ET | Source: SQZ Biotech

SQZ Biotech to Present at Upcoming Investor Conferences in November & December

WATERTOWN, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will...
November 07, 2019 08:00 ET | Source: SQZ Biotech

SQZ Biotech and AskBio Announce Research Collaboration to Create Immune Tolerization Products for AAV Gene Therapies

WATERTOWN, Mass. and RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), and Asklepios BioPharmaceutical, Inc. (AskBio), announced a research collaboration to...
November 05, 2019 08:01 ET | Source: SQZ Biotech

SQZ Biotech to Present First Time Data Demonstrating Potential of Company’s Second Novel Cell Therapy Approach in Oncology - Activating Antigen Carriers (AACs)

Preclinical data demonstrate SQZ AACs ability to prime antigen-specific T cell responses and drive tumor reduction in vivo SQZ to also present additional preclinical data on company’s first oncology...
October 31, 2019 08:00 ET | Source: SQZ Biotech

SQZ Biotech to Present New Data at the Society for Immunotherapy of Cancer’s 34th Annual Meeting

WATERTOWN, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will...
October 22, 2019 08:00 ET | Source: SQZ Biotech

SQZ Biotech Announces Clearance of US IND Application for First Clinical Trial

WATERTOWN, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing innovative treatments for multiple therapeutic areas, today announced that the...
September 17, 2019 08:00 ET | Source: SQZ Biotech

SQZ Biotech Appoints Legal Life Sciences Expert, Lawrence Knopf, as General Counsel

WATERTOWN, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment of...
August 07, 2019 16:30 ET | Source: SQZ Biotech

SQZ Biotech Announces Appointment of Experienced Pharmaceutical Executive Teri Loxam as Chief Financial Officer

WATERTOWN, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment of...
May 29, 2019 08:00 ET | Source: SQZ Biotech

SQZ Biotech Strengthens Board of Directors with Appointment of Leading Cell Therapy Expert and Biotech Veteran

WATERTOWN, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment of...
May 14, 2019 08:00 ET | Source: SQZ Biotech

SQZ Biotech to Present at Investor Conferences in May & June

WATERTOWN, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will...